Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma
Author:
Affiliation:
1. Department of Medical Oncology Yale University New Haven CT USA
2. Department of Pathology Yale University New Haven CT USA
3. Robert H. Lurie Comprehensive Cancer Center Northwestern University Medical Center Chicago IL USA
Funder
Novartis Pharmaceuticals Corporation
Novartis
Publisher
Wiley
Subject
Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.12847
Reference100 articles.
1. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
2. Circulating melanoma exosomes as diagnostic and prognosis biomarkers
3. Phase II trial of trametinib in combination with the AKT inhibitor GSK 2141795 in BRAF wild-type melanoma.
4. Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
5. Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oxidative State in Cutaneous Melanoma Progression: A Question of Balance;Antioxidants;2024-08-30
2. Development of Personalized Strategies for Precisely Battling Malignant Melanoma;International Journal of Molecular Sciences;2024-05-04
3. Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103);The Journal of Clinical Pharmacology;2024-01-17
4. Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors;Cancer Chemotherapy and Pharmacology;2024-01-11
5. Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy;Frontiers in Pharmacology;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3